Skip to main content
. 2018 Jan 30;8:1840. doi: 10.1038/s41598-018-20325-0

Figure 2.

Figure 2

Interaction patterns of pembrolizumab/PD-1 recognition surface involving the amino-acid residues and the water molecules. (a) and (b) heavy-chain (HC) residues; (c) light-chain (LC) residues.